AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)

By AHRMM

On November 21, 2013, AHRMM submitted electronically

comments

to the Division of Dockets Management (HFA-305), Food and Drug Administration, Department of Health and Human Services, regarding the 

Draft Guidance for Industry

on the global unique device identification database (GUDID), which was issued on September 24, 2013.

 
In the comment letter, AHRMM supports all of the outlined attributes identified for the GUDID system; however, AHRMM’s comments pertain to three specific GUDID attributes that we strongly recommended be included in the GUDID database requirements In AHRMM’s November 6, 2012, response to the UDI proposed rule:

  • Labeled as hazardous: End-users should always be aware of devices that may pose hazards in order to ensure safe handling as well as product integrity.
  • Contains radioactive isotopes (e.g., radioactive element and atomic number) This information is important for environmentally-safe disposal and end-user handling.
  • Has Safety Data Sheet (SDS) This information provides end-users with a reliable and readily-available source of information should an urgent need arise.

These three attributes no longer appear in the Draft Guidance Document. AHRMM reiterates that the above attributes should be added to the database requirements. These attributes provide critical information that can be the difference between whether a device contributes to or detracts from quality patient care.

Related Resources

Podcasts
Alarm Fatigue and Supply Chain's Role in Preventing It
Learn about how the significant number of clinical alarms have a numbing effect on nursing staff, to the point that patient safety is in jeopardy.
Podcasts
UDI and Providers: What You Need to Do
Get the basics on what healthcare supply chain and manufacturers, together with clinical and IT departments, must do to implement the Unique Device
On-Demand Educational Webinars
Managing the C-Suite to Attain Supply Chain Goals
Supply chain leaders are being charged with mission-critical tasks that require C-suite level engagement and buy-in. In this webinar, we discuss how…
Podcasts
The Meaningful Use 3 Rule
A short introduction to the CMS Meaningful Use 3 Rule and how implementing UDI within the healthcare setting and moving toward the full GS1 will re
Book
An Executive Decision: Understanding What Is Required to Reach the C-Suite
AHRMM created this book for engaged and motivated supply chain leaders in the making.
Webcast
Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve